STRO vs WAB · rev $62.0M vs P/E 38, rev $10.39B
Sutro Biopharma (STRO) versus Westinghouse Air Brake Technologies Corp (WAB) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Westinghouse Air Brake Technologies Corp (WAB) is a railroads company listed on NYSE.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported WAB revenue for 2024-12-31 was $10.39B. Net income was $1.07B. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
STRO currently screens at market cap $470.8M. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
Not investment advice. Open the STRO and WAB stock pages for the full models.
Not investment advice.